Conflict of interest: Nothing to declare.
Article first published online: 1 APR 2011
Copyright © 2011 Wiley-Liss, Inc.
Pediatric Blood & Cancer
Volume 57, Issue 1, pages 56–62, 15 July 2011
How to Cite
Champagne, M. A., Fu, C. H., Chang, M., Chen, H., Gerbing, R. B., Alonzo, T. A., Cooley, L. D., Heerema, N. A., Oehler, V., Wood, C., French, M. E., Arceci, R. J., Smith, F. O. and Bernstein, M. L. (2011), Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: A report from the Children's Oncology Group. Pediatr. Blood Cancer, 57: 56–62. doi: 10.1002/pbc.23031
Presented in part at American Society of Hematology, Orlando, 2006.
- Issue published online: 9 MAY 2011
- Article first published online: 1 APR 2011
- Manuscript Accepted: 16 DEC 2010
- Manuscript Received: 15 JUN 2010
- Chair's Grant. Grant Number: U10 CA98543-08
- National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Grant Number: U10 CA98413-08
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.